Mammalian multipotent neural stem cells
AssigneeCalifornia Institute of Technology
InventorsDavid J. Anderson, Derek L. Stemple
Life of this patent
Estimating the term…
Loading patent…
AssigneeCalifornia Institute of Technology
InventorsDavid J. Anderson, Derek L. Stemple
Estimating the term…
The invention includes mammalian multipotent neural stem cells and their progeny and methods for the isolation and clonal propagation of such cells. At the clonal level the stem cells are capable of self regeneration and asymmetrical division. Lineage restriction is demonstrated within developing clones which are sensitive to the local environment. The invention also includes such cells which are transfected with foreign nucleic acid, e.g., to produce an immortalized neural stem cell, and immortalized cell lines which are capable of subsequent disimmortalization. The invention further includes transplantation assays which allow for the identification of mammalian multipotent neural stem cells from various tissues and methods for transplanting mammalian neural stem cells and/or neural or glial progenitors into mammals. A novel method for detecting antibodies to neural cell surface markers is disclosed as well as a monoclonal antibody to mouse LNGFR.
A method for creating an immortalized cell line comprising transforming neural crest stem cells with a vector comprising an immortalizing gene flanked by recombinase target sites to create an immortalized cell line, wherein said neural crest stem cells are capable of self-renewal in a feeder cell-independent culture medium, express low-affinity nerve growth factor receptor (LNGFR) and nestin, but do not express neuronal or glial lineage markers including glial fibrillary acidic protein (GFAP), wherein at least one of said stem cells is capable of differentiation to a peripheral nervous system (PNS) neuronal cell that does not express LNGFR or nestin but does express neurofilament-160, and wherein at least one of said stem cells is capable of differentiation to a PNS glial cell that expresses LNGFR, nestin, and GFAP.
A method for creating immortalized neural crest stem cells in vitro that contain recombinase target sites flanking an immortalization gene in the genome of said immortalized cells, said method comprising transforming neural crest stem cells with exogeneous nucleic acid comprising:
A method for the in vitro disimmortalization of immortalized neural crest stem cells that contain exogeneous nucleic acid comprising recombinase target sites flanking an immortalization gene in the genome of said immortalized cells, said method comprising contacting said recombinase target sites with a recombinase capable of recognizing said recombinase target sites, wherein said neural crest stem cells are capable of self-renewal in a feeder cell-independent culture medium, express low-affinity nerve growth factor receptor (LNGFR) and nestin, but do not express neuronal or glial lineage markers including glial fibrillary acidic protein (GFAP), wherein at least one of said stem cells is capable of differentiation to a peripheral nervous system (PNS) neuronal cell that does not express LNGFR or nestin but does express neurofilament-160, and wherein at least one of said stem cells is capable of differentiation to a PNS glial cell that expresses LNGFR, nestin and GFAP.
A method for the in vitro disimmortalization of immortalized neural crest stem cells comprising:
A method for the in vitro disimmortalization of immortalized neural crest stem cells comprising:
A method for the in vitro disimmortalization of immortalized neural crest stem cells comprising:
Dependencies are inferred from the claim text.